Back
Pharming Group 10K Form
Buy
63
PHAR
Pharming Group
Last Price:
$10.40
Seasonality Move:
-2.11%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PHAR News And Ratings
See the #1 stock for the next 7 days that we like better than PHAR
PHAR Financial Statistics
Sales & Book Value
| Annual Sales: | $245.3M |
|---|---|
| Cash Flow: | $9.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.33 |
| Price / Book: | 2.73 |
Profitability
| EPS (TTM): | -0.27000 |
|---|---|
| Net Income (TTM): | $-17.8M |
| Gross Margin: | $220.1M |
| Return on Equity: | -8.24% |
| Return on Assets: | -4.08% |
Pharming Group Earnings Forecast
Key Pharming Group Financial Ratios
-
The Gross Profit Margin over the past 18 years for PHAR is 89.72%.
-
The Selling, General & Administrative Expenses for PHAR have been equal to 35.67% of Gross Profit Margin.
-
The Research & Development expenses have been 28.09% of Revenue.
-
The Interest Expense is -56.54% of Operating Income.
-
The Net Earning history of PHAR is -4.30% of Total Revenues.
-
Per Share Earnings over the last 19 years have been positive in 8 years.
Pharming Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PHAR |
| Website: | pharming.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 3.53 |
| Quick Ratio: | 2.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 627.59 |
PHAR Technical Analysis vs Fundamental Analysis
Buy
63
Pharming Group (PHAR)
is a Buy
Is Pharming Group a Buy or a Sell?
-
Pharming Group stock is rated a BuyThe current Pharming Group [PHAR] share price is $9.10. The Score for PHAR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.